Skip to content

Clinical trials

Active, not recruiting Phase 1/2 Carcinoma, Non-Small-Cell Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1/2 Status: Active, not recruiting Clear all

77 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20151
20164
20173
20183
201913
20208
20219
202212
202311
20246
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting77

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center5
AstraZeneca4
Eli Lilly and Company3
Novartis Pharmaceuticals3
Sichuan Baili Pharmaceutical Co., Ltd.3
Bristol-Myers Squibb2
H. Lee Moffitt Cancer Center and Research Institute2
Janssen Research & Development, LLC2
Servier Bio-Innovation LLC2
A2 Biotherapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung77
Lung Neoplasms16
Colorectal Neoplasms15
Melanoma11
Stomach Neoplasms11
Squamous Cell Carcinoma of Head and Neck10
Neoplasms8
Ovarian Neoplasms8
Neoplasm Metastasis7
Pancreatic Neoplasms7

Trials

Showing 1 to 25 of 77. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.